Lupin's generic Clarinex gets FDA approval
SILVER SPRING, Md. The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for allergies, according to FDA records.
The drug is a generic version of Schering-Plough’s Clarinex.
Clarinex has annual sales of around $229 million, according to IMS Health data reported by several media in India, where Lupin is based.